Latest News about REGN
Recent news which mentions REGN
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
April 07, 2022
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
April 06, 2022
Tickers
REGN
From Benzinga
BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week in latest sign of how dominant it has become
April 06, 2022
From MarketWatch
7 Safe Stocks to Buy to Guard Against a Recession
April 05, 2022
From InvestorPlace
Annual Boosters Might Not Give Moderna the Boost It Needs
April 05, 2022
From InvestorPlace
Executives Sell More Than $262M Of 5 Stocks
April 04, 2022
From Benzinga
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
From Benzinga
Regeneron-Sanofi's Dupixent Significantly Improved Signs, Symptoms In Chronic Itchy Skin Disease
March 28, 2022
From Benzinga
3 Top Stock-Split Candidates After Amazon and Alphabet
March 25, 2022
From Motley Fool
Amazon Stock Split: 3 Companies That Should Follow Suit
March 24, 2022
From Motley Fool
From Benzinga
1 Great Income Stock to Buy and Hold Forever
March 16, 2022
From Motley Fool
From Benzinga
Is Regeneron Stock a Buy Now?
March 11, 2022
From Motley Fool
From InvestorPlace
From Benzinga
3 Top Healthcare Stocks to Buy for March
March 06, 2022
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
Viatris Just Snagged a Major FDA Approval
March 03, 2022
From Motley Fool
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
From Motley Fool
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.